x

Apogee Therapeutics, Inc. (Nasdaq:APGE)

Health Care/Life Sciences • Biotechnology
CIK 1974640
Company

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Address
221 Crescent Street
Building 17, Suite 102b
Waltham, Massachusetts 02453
Employees
None
Stock Info
Close
$31.43
Day Range
29.26 - 31.56
52 Week Range
29.10 - 72.29
Average volume
555.57K
Short Interest
8.32M (02/14/25)
% of Float Shorted
22.53%
Market Cap
$1.87B
Revenue
N/A
Net Income
-$83.99M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$3.23
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Mark C. Mckenna
Chief Executive Officer & Director
Michael Henderson
Secretary, Director & Chief Legal Officer
Matthew Batters
Independent Director
William A. Jones Jr.
Independent Director
Tomas Kiselak
Independent Director
Peter Harwin
Independent Director
Andrew Gottesdiener
Independent Director
Nimish P. Shah
Director
Lisa L. Bollinger
Independent Director
Jennifer Fox
SEC filings
DateFormEvent
16 Dec, 2024 4
13 Dec, 2024 4
11 Dec, 2024 144
11 Dec, 2024 4
11 Dec, 2024 4
11 Dec, 2024 4
10 Dec, 2024 8-K
6 Dec, 2024 4
6 Dec, 2024 4
4 Dec, 2024 144
2 Dec, 2024 8-K
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G
14 Nov, 2024 SC 13G/A
12 Nov, 2024 8-K
12 Nov, 2024 SC 13G/A
12 Nov, 2024 10-Q
8 Nov, 2024 4
8 Nov, 2024 SC 13G
8 Nov, 2024 4
6 Nov, 2024 144
4 Nov, 2024 SC 13G/A
24 Oct, 2024 8-K
22 Oct, 2024 SC 13G
4 Oct, 2024 4
4 Oct, 2024 SC 13G
4 Oct, 2024 4
2 Oct, 2024 144
2 Oct, 2024 144
6 Sep, 2024 4
6 Sep, 2024 4
4 Sep, 2024 144
23 Aug, 2024 144
23 Aug, 2024 4
19 Aug, 2024 8-K
12 Aug, 2024 10-Q
12 Aug, 2024 8-K
12 Aug, 2024 S-8
12 Aug, 2024 S-3ASR
9 Aug, 2024 4
9 Aug, 2024 4
7 Aug, 2024 144
5 Jul, 2024 4
5 Jul, 2024 4
5 Jul, 2024 144
3 Jul, 2024 144
7 Jun, 2024 4
7 Jun, 2024 8-K
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
30 May, 2024 4
30 May, 2024 3
28 May, 2024 8-K
28 May, 2024 DEFA14A
15 May, 2024 8-K
13 May, 2024 10-Q
13 May, 2024 8-K
13 May, 2024 S-8
24 Apr, 2024 DEFA14A
24 Apr, 2024 DEF 14A
24 Apr, 2024 ARS
1 Apr, 2024 SC 13D/A
1 Apr, 2024 4
25 Mar, 2024 8-K
11 Mar, 2024 424B4
7 Mar, 2024 S-1MEF
7 Mar, 2024 EFFECT
5 Mar, 2024 CORRESP
5 Mar, 2024 10-K
5 Mar, 2024 S-1
5 Mar, 2024 8-K
5 Mar, 2024 8-K
5 Mar, 2024 CORRESP
29 Feb, 2024 UPLOAD
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G/A
9 Feb, 2024 DRS
9 Feb, 2024 SC 13G/A
31 Jan, 2024 SC 13D/A
31 Jan, 2024 4
20 Dec, 2023 4
20 Dec, 2023 4
20 Dec, 2023 4
13 Nov, 2023 10-Q
13 Nov, 2023 8-K
3 Nov, 2023 SC 13G
28 Aug, 2023 8-K
28 Aug, 2023 S-8
28 Aug, 2023 10-Q
21 Aug, 2023 8-K
21 Aug, 2023 4
21 Aug, 2023 3
10 Aug, 2023 SC 13G
7 Aug, 2023 8-K
28 Jul, 2023 SC 13D
25 Jul, 2023 SEC STAFF
24 Jul, 2023 SC 13G
21 Jul, 2023 SC 13D
17 Jul, 2023 3/A
17 Jul, 2023 4
17 Jul, 2023 4
17 Jul, 2023 424B4 IPO completed
17 Jul, 2023 4
17 Jul, 2023 3/A
17 Jul, 2023 3/A
17 Jul, 2023 3/A
17 Jul, 2023 3/A
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 S-1MEF
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
12 Jul, 2023 CERT
11 Jul, 2023 CORRESP
11 Jul, 2023 CORRESP
10 Jul, 2023 CORRESP
10 Jul, 2023 8-A12B
10 Jul, 2023 S-1/A
3 Jul, 2023 S-1/A
30 Jun, 2023 UPLOAD
22 Jun, 2023 CORRESP
22 Jun, 2023 S-1
16 Jun, 2023 UPLOAD
12 Jun, 2023 SEC STAFF
5 Jun, 2023 DRS/A
5 Jun, 2023 DRSLTR
2 Jun, 2023 UPLOAD
28 Apr, 2023 DRS
Last update:2025-03-06 12:24:43.530255
Apogee Therapeutics, Inc. by TradingView

Sign Up to Subscribe